Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Life and Health Insurance Industry Analysis

UpdatedJun 09, 2026
DataAggregated Company Financials
Companies21
  • 7D2.8%
  • 3M12.1%
  • 1Y11.3%
  • YTDn/a

The Life and Health Insurance industry has gained 3.3% in the last week and MetLife up 3.1%. This takes the industry's 12 month performance to a gain of 12%. As for the next few years, earnings are expected to grow by 8.4% per annum.

Industry Valuation and Performance

Has the U.S. Life and Health Insurance Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 09 Jun 2026US$252.8bUS$264.8bUS$18.7b14.5x13.5x1x
Thu, 07 May 2026US$249.1bUS$264.5bUS$18.4b14.9x13.6x0.9x
Sat, 04 Apr 2026US$232.1bUS$260.6bUS$16.6b14.6x13.9x0.9x
Mon, 02 Mar 2026US$235.4bUS$260.6bUS$16.6b14.9x14.1x0.9x
Wed, 28 Jan 2026US$240.9bUS$255.6bUS$19.7b12.9x12.2x0.9x
Fri, 26 Dec 2025US$253.3bUS$255.6bUS$19.7b13.1x12.8x1x
Sun, 23 Nov 2025US$241.5bUS$255.6bUS$19.7b12.3x12.2x0.9x
Tue, 21 Oct 2025US$242.8bUS$254.5bUS$15.7b13x15.5x1x
Thu, 18 Sep 2025US$248.3bUS$254.5bUS$15.7b13.6x15.9x1x
Sat, 16 Aug 2025US$245.4bUS$254.5bUS$15.7b13.5x15.7x1x
Mon, 14 Jul 2025US$241.4bUS$257.6bUS$18.1b12.1x13.3x0.9x
Wed, 11 Jun 2025US$225.6bUS$243.3bUS$17.6b12.3x12.8x0.9x
Fri, 09 May 2025US$226.8bUS$241.0bUS$19.4b12.4x11.7x0.9x
Sun, 06 Apr 2025US$213.0bUS$250.3bUS$22.4b10.1x9.5x0.9x
Tue, 04 Mar 2025US$241.5bUS$248.8bUS$22.5b11.1x10.8x1x
Thu, 30 Jan 2025US$241.9bUS$242.9bUS$14.3b14.6x17x1x
Sat, 28 Dec 2024US$232.5bUS$242.9bUS$14.3b13.6x16.3x1x
Mon, 25 Nov 2024US$248.3bUS$242.9bUS$14.3b14.8x17.4x1x
Wed, 23 Oct 2024US$244.6bUS$229.8bUS$16.6b13.7x14.7x1.1x
Fri, 20 Sep 2024US$238.9bUS$229.8bUS$16.6b13.3x14.4x1x
Sun, 18 Aug 2024US$227.1bUS$229.8bUS$16.6b12.5x13.7x1x
Tue, 16 Jul 2024US$223.9bUS$222.7bUS$14.7b9.9x15.2x1x
Thu, 13 Jun 2024US$213.9bUS$225.4bUS$14.8b10.4x14.4x0.9x
Sat, 11 May 2024US$214.6bUS$225.4bUS$14.8b12.4x14.5x1x
Mon, 08 Apr 2024US$222.9bUS$216.9bUS$10.3b16.9x21.7x1x
Wed, 06 Mar 2024US$212.4bUS$216.9bUS$10.2b15.9x20.9x1x
Fri, 02 Feb 2024US$251.0bUS$213.2bUS$3.1b13.3x80.2x1.2x
Sun, 31 Dec 2023US$255.8bUS$216.4bUS$1.6b13.4x157.1x1.2x
Tue, 28 Nov 2023US$247.8bUS$216.4bUS$1.6b12.9x152.1x1.1x
Thu, 26 Oct 2023US$235.7bUS$238.9bUS$1.0b12.5x230.5x1x
Sat, 23 Sep 2023US$244.1bUS$238.9bUS$1.0b12.9x238.8x1x
Mon, 21 Aug 2023US$241.4bUS$238.9bUS$1.0b13.2x236.1x1x
Wed, 19 Jul 2023US$241.0bUS$240.0bUS$5.5b12.8x43.9x1x
Fri, 16 Jun 2023US$226.1bUS$240.0bUS$5.5b12.6x41.2x0.9x
Price to Earnings Ratio

41.2x


Total Market Cap: US$226.1bTotal Earnings: US$5.5bTotal Revenue: US$240.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Life and Health Insurance Industry Price to Earnings3Y Average 42.5x202420252026
Current Industry PE
  • Investors are pessimistic on the American Life and Health Insurance industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 13.5x which is lower than its 3-year average PE of 42.5x.
  • The industry is trading close to its 3-year average PS ratio of 0.99x.
Past Earnings Growth
  • The earnings for companies in the Life and Health Insurance industry have grown 50% per year over the last three years.
  • Revenues for these companies have grown 3.3% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Life and Health Insurance compare with similar industries?

US Market-2.73%
Financials0.48%
Insurance2.17%
Life and Health Insurance2.77%
Property and Casualty Insurance2.57%
General Insurance1.98%
Reinsurance1.73%
Insurance Brokers0.69%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MET MetLifeUS$84.383.1%
+US$1.6b		6.0%PE15.8x
AFL AflacUS$115.242.8%
+US$1.6b		12.4%PE12.7x
OSCR Oscar HealthUS$27.3919.2%
+US$1.3b		85.6%PS0.6x
PRU Prudential FinancialUS$103.723.2%
+US$1.1b		-2.0%PE10.5x
UNM Unum GroupUS$87.024.3%
+US$573.6m		8.2%PE17.8x

Latest News

MET
US$84.38
MetLife
7D
3.1%
1Y
6.0%
Seeking Alpha • 15h

MetLife: Not Exciting, But It Works

Summary MetLife delivers strong Q1 2026 results with adjusted EPS up 23% to $2.42 and ROE at 17%, highlighting robust core performance. I find MET's fixed-income preferreds, especially Series F, compelling with yields near 6.5% and payout ratios under 4%, offering rare quality and safety. Common shares trade at a fair 8.5x forward P/E with limited near-term upside; total equity returns approximate 8% annually via buybacks and dividends. Key risks include commercial mortgage exposure and volatile alternative investment income, but preferred dividend coverage remains exceptionally strong. Read the full article on Seeking Alpha
BNT
US$44.05
Brookfield Wealth Solutions
7D
-2.8%
1Y
12.9%
PRI
US$263.01
Primerica
7D
-1.3%
1Y
0.3%
Narrative Update • Jun 07

PRI: Future Returns Will Be Shaped By Distribution Shift And Capital Returns

Analysts have nudged their price target for Primerica higher from $295.83 to $298.50, citing updated assumptions for revenue growth, profit margins and future P/E that modestly increase their view of the stock's fair value. What's in the News Primerica reported Q1 2026 adjusted operating revenues up 9%, with adjusted operating EPS up 19%, according to company results released on June 1, 2026.
AFL
US$115.24
Aflac
7D
2.8%
1Y
12.4%
PFG
US$105.03
Principal Financial Group
7D
2.1%
1Y
36.7%
OSCR
US$27.39
Oscar Health
7D
19.2%
1Y
85.6%
CNO
US$47.99
CNO Financial Group
7D
4.4%
1Y
25.7%
PRU
US$103.72
Prudential Financial
7D
3.2%
1Y
-2.0%
GL
US$157.13
Globe Life
7D
3.3%
1Y
30.2%
Narrative Update • Jun 02

GL: Buybacks And Higher Earnings Guidance Will Support Bullish Outlook

Analysts have raised Globe Life's fair value estimate from $199.00 to $208.00 per share, citing updated assumptions around revenue growth, discount rate, profit margin, and future P/E, which together support a slightly higher long-term price target. What's in the News Globe Life reported that from January 1, 2026 to March 31, 2026, it repurchased 1,400,000 shares, or 1.77% of shares, for US$203m under its long running buyback program announced on August 5, 2005.
UNM
US$87.02
Unum Group
7D
4.3%
1Y
8.2%
Narrative Update • Jun 01

UNM: Buybacks And Mortality Trends Will Support Returns Through Sector Headwinds

Analysts have nudged the implied fair value for Unum Group higher to about $97.62 from roughly $95.08, as recent price target increases, backed by views of generally strong life insurance results, ongoing earnings momentum and improvements in mortality, offset a smaller number of target trims across the sector. Analyst Commentary Recent research on Unum Group reflects a mix of optimism and caution, with several price target increases around life insurance results and a few trims tied to sector wide valuation questions.
BHF
US$62.54
Brighthouse Financial
7D
-0.2%
1Y
6.2%
Narrative Update • Jun 01

BHF: Market Perform Reinitiation Will Support Path Toward US$70 Fair Value

Analysts have kept Brighthouse Financial's fair value estimate steady at $70.00 while fine tuning assumptions on the discount rate, revenue growth, profit margin, and future P/E. This aligns with recent Street research that re-initiated the stock at Market Perform.
CIA
US$5.30
Citizens
7D
-1.1%
1Y
44.8%
Analysis Article • May 11

Citizens, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Citizens, Inc. ( NYSE:CIA ) missed earnings with its latest first-quarter results, disappointing overly-optimistic...